The Schall Law Firm is handling a class action lawsuit against Applied Therapeutics, Inc. (NASDAQ: APLT) for alleged securities law violations between January 3, 2024, and December 2, 2024. The company is accused of making false statements and failing to follow proper clinical trial protocols for its drug candidate, govorestat, risking FDA rejection of its data. Shareholders who suffered losses can join the case by February 18, 2025.
The Schall Law Firm reminds investors of a class action lawsuit against Customers Bancorp, Inc. (NYSE: CUBI) for alleged violations of the Securities Exchange Act of 1934. The lawsuit claims Customers Bancorp issued false and misleading statements regarding its anti-money laundering procedures and regulatory compliance, leading to investor damages. Shareholders who purchased securities between March 1, 2024, and August 8, 2024, have until January 31, 2025, to participate as lead plaintiffs.
The Schall Law Firm reminds investors of a class action lawsuit against ASML Holding NV (NASDAQ: ASML) for alleged violations of the Securities Exchange Act of 1934. The lawsuit alleges that ASML made false and misleading statements about problems in the semiconductor industry, sales recovery, and growth projections, resulting in losses to investors. The lawsuit covers the period from January 24, 2024, through October 15, 2024. Suspected investors have until January 13, 2025, to join the case.
